GCG and type 2 diabetes mellitus: Of these hormones, GIP and GLP-1, commonly referred to as incretins, modulate postprandial glucose concentrations by inducing a rapid and strong insulinotropic effect after meal ingestion, which is blunted in patients with T2D (48) and has been widely explored as pharmaceutical target for T2D.